Luoma et al. Tissue-resident memory and circulating T cells are early responders to pre-surgical cancer immunotherapy. Cell (2022) Discovery of Tumor Antigens and TCRs for the Treatment of Solid Tumors.

Kula et al. T-Scan: A Genome-wide Method for the Systematic Discovery of T Cell Epitopes. Cell (2019) Pioneering work on the TargetScan discovery platform.

Ferretti et al. Unbiased Screens Show CD8+ T Cells of COVID-19 Patients Recognize Shared Epitopes in SARS-CoV-2 that Largely Reside outside the Spike Protein. Immunity (2020) TargetScan platform used to identify SARS-CoV-2 targets of T cells in recovering COVID-19 patients.


Jurewicz et al. Discovery of PRAME-specific TCR-T cell therapy candidates for the treatment of solid tumors. SITC 2022

Boudot et al. Multiplexed TCR-T Cell Therapy Targeting MAGE-A1 and PRAME Enhances The Activity of Adoptive T Cell Therapy in Pre-Clinical Models. SITC 2022

Jangalwe et al. Discovery of TSC-200-A02: A Natural HPV16 E7-specific TCR-T Cell Therapy Candidate for the Treatment of HPV-positive Solid tumors. ASGCT 2022

Wang et al. Multiplexed TCR-T Therapy: A Strategy to Enhance the Efficacy of Engineered Adoptive Cell Therapy. ASGCT 2022

Chattopadhyay et al. Product Characteristics and Multi-Arm Clinical Trial Design for TSC-100 and TSC-101, TCR-T Cells That Target Leukemia Following Hematopoietic Cell Transplantation. ASH 2021

Nayar R. et al. Discovery of TSC-101: A First in Class Natural HA-2 Specific TCR to Treat Leukemia Following Hematopoietic Stem Cell Transplant Therapy. ASH 2021

Wang et al. Comprehensive Identification of Tumor-reactive TCRs and Cognate Targets for Novel TCR T-cell Cancer Therapies. ASGCT (2020)

Ferretti et al. Unbiased Genome-wide Discovery Using TScan Reveals Shared Immunodominant CD8+ T Cell Epitopes in SARS-CoV-2. ASGCT (2020)

Nayar et al. Discovery of TSC-100: A Natural HA-1-specific TCR to Treat Leukemia Following Hematopoietic Stem Cell Transplant Therapy. SITC (2020)


Corporate Presentation – May 2022

MacBeath, Discovery of immunodominant T cell targets in COVID-19 patients and design of novel T cell-based vaccines, Cell-Mediated Therapies for Infectious Disease Summit (2021)